Affluent Partners Holdings' (HKG:1466) subsidiary Beijing Baijin Biotechnology agreed to cooperate with Hangzhou Changwei Hospital to establish a smart medical service model with specialized expertise and treatment, a Wednesday filing with the Hong Kong Exchange said.
The parties will utilize their complementary advantages to create a smart medical service system which will cover medical treatment, teaching, and scientific research.
The service model will include a smart medical information system, specialty and disease-based treatment and management smart medical service platforms, and a specialty-specific smart medical management system.
The Jewelry maker and trader's shares were up 14% on Wednesday's close.
Price (HKD): $0.57, Change: $+0.070, Percent Change: +14.00%